Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 6WYT | 6WYT | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1B | |
| 6WZT | 6WZT | CryoEM structure of influenza hemagglutinin A/Victoria/361/2011 in complex with cyno antibody 3B10 | Hemagglutinin, Cyno antibody light chain, Cyno antibody heavy chain |
| 6X1T | 6X1T | Structure of pHis Fab (SC50-3) in complex with pHis mimetic peptide | |
| 6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | Gamma-aminobutyric acid receptor subunits beta-2, alpha-1, gamma-2, Kappa Fab Light Chain, IgG2b Fab Heavy Chain |
| 6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | Gamma-aminobutyric acid receptor subunits beta-2, alpha-1, gamma-2, Kappa Fab Light Chain, IgG2b Fab Heavy Chain |
| 6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
| 6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
| 6X3U | 6X3U | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil | |
| 6X3U | 6X3U | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil | |
| 6X3V | 6X3V | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate | |
| 6X3V | 6X3V | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate | |
| 6X3W | 6X3W | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital | |
| 6X3W | 6X3W | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital | |
| 6X3X | 6X3X | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam | |
| 6X3X | 6X3X | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam | |
| 6X3Z | 6X3Z | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA | |
| 6X3Z | 6X3Z | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA | |
| 6X40 | 6X40 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin | |
| 6X40 | 6X40 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin | |
| 6X4G | 6X4G | Crystal structure of ICOS in complex with ICOS-L and an anti ICOS-L VNAR domain | |
| 6X4T | 6X4T | Crystal structure of ICOS-L in complex with Prezalumab and VNAR domain | |
| 6X5B | 6X5B | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 6X5R | 6X5R | Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and A2-Asn | |
| 6X5S | 6X5S | Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and A3'-Asn | |
| 6X96 | 6X96 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment antigen binding variable domain | |
| 6X97 | 6X97 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment antigen binding variable domain | |
| 6X98 | 6X98 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment antigen binding variable domain | |
| 6X9R | 6X9R | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9S | 6X9S | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9T | 6X9T | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9U | 6X9U | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9V | 6X9V | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6XC2 | 6XC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
| 6XC3 | 6XC3 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 | |
| 6XC4 | 6XC4 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
| 6XC7 | 6XC7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
| 6XC9 | 6XC9 | Immune receptor complex | |
| 6XC9 | 6XC9 | Immune receptor complex | |
| 6XCJ | 6XCJ | Crystal Structure of DH650 Fab from a Rhesus Macaque in Complex with HIV-1 gp120 Core | |
| 6XCM | 6XCM | Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1) | Spike glycoprotein, C105 Fab Heavy Chain, C105 Fab Light Chain |
| 6XCN | 6XCN | Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2) | Spike glycoprotein, C105 Fab Heavy Chain, C105 Fab Light Chain |
| 6XCO | 6XCO | Immune receptor complex | |
| 6XCO | 6XCO | Immune receptor complex | |
| 6XCP | 6XCP | Immune receptor complex | |
| 6XCP | 6XCP | Immune receptor complex | |
| 6XDG | 6XDG | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies | Spike glycoprotein, REGN10933 antibody Fab fragment light chain, REGN10933 antibody Fab fragment heavy chain, REGN10987 antibody Fab heavy chain, REGN10987 antibody Fab fragment light chain |
| 6XE1 | 6XE1 | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab | |
| 6XEY | 6XEY | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XGC | 6XGC | CryoEM structure of influenza hemagglutinin A/Michigan/45/2015 in complex with cyno antibody 1C4 | Hemagglutinin, Cyno antibody light chain, Cyno antibody heavy chain |
| 6XI2 | 6XI2 | Apo form of POMGNT2 | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (E.C.2.4.1.312), ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA, ALA-GLY-ALA-GLY-ALA-ALA-ALA-ALA-ALA-ALA |
